Biogen Idec, Inc. (NQ:BIIB)
Delayed: 225.18 --0 (-0%)
Trade Now!
Previous Close $225.18    52 Week High $234.46 
Open $226.05    52 Week Low $126.39 
Day High $234.46    P/E 35.74 
Day Low $224.33    EPS $6.30 
Volume 272,076       

Friends, Peers and Foes (?): ELN, AMGN, BMY, ABT, RBCC (more...)

May 21, 2013 05:00 AM RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
May 21, 2013 04:30 AM Biogen Idec Submits Application to FDA for Approval of PLEGRIDY™ (Peginterferon Beta-1a) in Multiple Sclerosis
May 20, 2013 04:43 PM Biogen's (BIIB) BG-12 Data Not Inflated
May 20, 2013 10:06 AM Biogen (BIIB) Weeks-6 TECFIDERA Scripts Continue to Ramp
May 13, 2013 09:41 AM Biogen's (BIIB) TECFIDERA Scripts Accelerating WoW
May 13, 2013 09:31 AM StreetInsider.com Pre-Open Movers 5/13: (THRX) (MTSN) (TSLA) Higher; (AFFY) (CEL) (UNXL) Lower (more...)
May 13, 2013 07:31 AM Biogen (BIIB) BLA for ELOCTATE Accepted by FDA
May 13, 2013 07:30 AM FDA Accepts Biogen Idec’s Biologics License Application for First Long-Lasting Factor VIII Therapy for Hemophilia A
May 13, 2013 05:00 AM RBCC Partner n3D Signs U.S. Distribution Agreement
May 7, 2013 01:37 PM Form 4 BIOGEN IDEC INC. For: May 03 Filed by: Pawlicki Raymond
View All Articles

Entities mentioned with BIIB

View All Entities